BILL · 2019–20 SESSION
SB 5940: Rx opioid drugs B&O surtax
Imposing a business and occupation surtax on prescription opioid drugs.
Summary
- Establishes a business and occupation surtax on the gross income derived from the sale of prescription opioid drugs.
From the Senate Bill Report (Orig.) (SB 5940), written by the Legislature's nonpartisan staff. Read the full report ↗
Did not pass Did not pass · died in committee
- IntroducedFeb 18, 2019
- Out of committeestopped here
- Passed Senate
- Passed House
- Governor
- Law
- Prime sponsor
- Karen Keiser (D-33)
- Introduced
- February 18, 2019 in the Senate
- Last action
- January 13, 2020
- Budget
- Has a fiscal note
AN ACT Relating to imposing a business and occupation surtax on prescription opioid drugs;
Sponsors
Votes
No recorded floor votes. This measure never reached a floor vote.
History
- By resolution, reintroduced and retained in present status.
- First reading, referred to Ways & Means.
SB 5940 in other sessions
Bill numbers restart every two years, so the same number is a different bill in each session.
- SB 5940 (2025–26) Foster care housing pilot
- SB 5940 (2023–24) Medical assistant-EMT cert.
- SB 5940 (2021–22) Liquor license endorsement
- SB 5940 (2017–18) Hanford/occupational disease
- SB 5940 (2015–16) Cougar control pilot program
- SB 5940 (2013–14) Estate tax applicable rates
- SB 5940 (2011–12) School employee benefits
- SB 5940 (2009–10) Wastewater treatment